1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Nicotine Addiction: new trials by email Literature Review of Nicotine Addiction trials Research Report on Nicotine Addiction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide for Smoking Cessation in Patients With Diabetes Semaglutide, Nicotine replacement - Diabetes Mellitus, Type 2, Nicotine Addiction | Phase 3 | Recruiting | Ottawa Heart Institute Research Corporation | 100 | 2026-02-13 | 2026-09-08 |
| Pharmacogenetics of Nicotine Addiction Treatment Varenicline, Placebo, Transdermal Nicotine - Nicotine Addiction | Phase 3 | Completed | University of Pennsylvania | 1246 | 2010-12-01 | 2016-03-03 |
Tobacco Use Disorder (2) · Diabetes Mellitus, Type 2 (1) · Smoking (1)
Chemically-Induced Disorders (2) · Mental Disorders (2) · Substance-Related Disorders (2) · Behavior (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Nicotine (1) · Nicotine Replacement Therapy (1) · Tobacco Use Cessation Devices (1) · Varenicline (1) · semaglutide (1)
Ottawa Heart Institute Research Corporation (1) · University of Pennsylvania (1)
Canada (2) · United States (1)
Caryn Lerman, PhD (1) · Rachel F Tyndale, PhD (1)
PMID 25012994, PMID 25588294, PMID 25732567, PMID 29986268, PMID 30614717, PMID 30946162, PMID 31502736, PMID 33300144, PMID 33713409, PMID 35639828, PMID 36789481, PMID 38369951, PMID 40174410, PMID 40358028
U01DA020830 (1)